Simcere Pharmaceutical Group (Simcere) is a holding company. The Company principally engaged in the research, development, manufacture and distribution of pharmaceutical and vaccine products in the People's Republic of China. Company markets and sells its products directly or indirectly to approximately 1,405 pharmaceutical distributors who in turn sell these products to other distributors, hospitals and retail pharmacies throughout China. As of March 31, 2013, the Company also had over 11 product candidates in various stages of development, including treatments for cancer and cardiovascular diseases. In December 2013, Simcere completed the merger contemplated by the previously announced Agreement and Plan of Merger among the Company, Simcere Holding Limited (Parent) and Simcere Acquisition Limited (Merger Sub), and as a result of the merger, the Company became a wholly owned subsidiary of Parent.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNYSE:SCR
Previous Symbol
CUSIPN/A
Phone+86-25-85566666
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable
Simcere Pharmaceutical Group (NYSE:SCR) Frequently Asked Questions
What is Simcere Pharmaceutical Group's stock symbol?
Simcere Pharmaceutical Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "SCR."
Has Simcere Pharmaceutical Group been receiving favorable news coverage?
News coverage about SCR stock has been trending positive recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Simcere Pharmaceutical Group earned a news sentiment score of 2.2 on InfoTrie's scale. They also assigned headlines about the healthcare company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future.
How do I buy shares of Simcere Pharmaceutical Group?
Shares of SCR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Simcere Pharmaceutical Group's stock price today?
One share of SCR stock can currently be purchased for approximately $8,000.00.
What is Simcere Pharmaceutical Group's official website?
How can I contact Simcere Pharmaceutical Group?
Simcere Pharmaceutical Group's mailing address is No.699-18 Xuan Wu Avenue Xuan Wu District, NANJING, JNG 210042, China. The healthcare company can be reached via phone at +86-25-85566666.
MarketBeat Community Rating for Simcere Pharmaceutical Group (NYSE SCR)
MarketBeat's community ratings are surveys of what our community members think about Simcere Pharmaceutical Group and other stocks. Vote "Outperform" if you believe SCR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCR will underperform the S&P 500 over the long term. You may vote once every thirty days.
